CD274 and neoplasm: In turn, this would recruit/prime/activate potentially anti-tumor T cells, the activity of which anti-PD-L1 ICI therapy would be able to potentiate further, thereby generating superior anti-tumor therapy to either therapy alone26, 27, 28, 29, 30, 31, 32.